Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever

A. L. Bisno, X. Berrios, F. Quesney, D. M. Monroe, James Dale, E. H. Beachey

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Group A streptococci of M protein type 5 have been epidemiologically related to acute rheumatic fever in a number of reported outbreaks. Preliminary bacteriological evidence suggests that M5 may be an important 'rheumatogenic' type in Santiago, Chile. To assess further the relationship of this streptococcal serotype to rheumatic fever in Chile, sera of 34 patients with rheumatic fever and a equal number of age-, sex-, and race-matched controls were assayed for antibodies to types 5, 6, and 24 in an enzyme-linked immunosorbent assay with purified pepsin extracts of the respective M proteins as solid-phase antigens. Sera of 11 rheumatic fever patients (32%) were positive (titer > 1:800) for type 5 antibodies, but only 1 (3%) of the matched controls was positive (P < 0.01). Neither the patients nor the controls had antibodies to type 24. Although 38% of the patient sera contained antibodies to type 6, 29% of the control sera also had such antibodies (P > 0.20). The enzyme-linked immunosorbent assay served as an accurate predictor of which sera contained type 5 opsonic antibodies as measured by the opsonophagocytic test. Although antigenic cross-reactivity exists between M protein type 5 and type 6 group A streptococci, this phenomenon is unlikely to have accounted for the preferential occurrence of type 5 antibodies in rheumatic fever sera. The enzyme-linked immunosorbent assay and opsonic antibody results suggest that M5 is an important rheumatogenic type in Chile.

Original languageEnglish (US)
Pages (from-to)573-579
Number of pages7
JournalInfection and Immunity
Volume38
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Rheumatic Fever
Chile
Antibodies
Enzyme-Linked Immunosorbent Assay
Streptococcus
Serum
Proteins
Pepsin A
Disease Outbreaks
streptococcal M protein
Antigens

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. / Bisno, A. L.; Berrios, X.; Quesney, F.; Monroe, D. M.; Dale, James; Beachey, E. H.

In: Infection and Immunity, Vol. 38, No. 2, 1982, p. 573-579.

Research output: Contribution to journalArticle

Bisno, A. L. ; Berrios, X. ; Quesney, F. ; Monroe, D. M. ; Dale, James ; Beachey, E. H. / Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. In: Infection and Immunity. 1982 ; Vol. 38, No. 2. pp. 573-579.
@article{005faae1f96543ffb600841b2225748a,
title = "Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever",
abstract = "Group A streptococci of M protein type 5 have been epidemiologically related to acute rheumatic fever in a number of reported outbreaks. Preliminary bacteriological evidence suggests that M5 may be an important 'rheumatogenic' type in Santiago, Chile. To assess further the relationship of this streptococcal serotype to rheumatic fever in Chile, sera of 34 patients with rheumatic fever and a equal number of age-, sex-, and race-matched controls were assayed for antibodies to types 5, 6, and 24 in an enzyme-linked immunosorbent assay with purified pepsin extracts of the respective M proteins as solid-phase antigens. Sera of 11 rheumatic fever patients (32{\%}) were positive (titer > 1:800) for type 5 antibodies, but only 1 (3{\%}) of the matched controls was positive (P < 0.01). Neither the patients nor the controls had antibodies to type 24. Although 38{\%} of the patient sera contained antibodies to type 6, 29{\%} of the control sera also had such antibodies (P > 0.20). The enzyme-linked immunosorbent assay served as an accurate predictor of which sera contained type 5 opsonic antibodies as measured by the opsonophagocytic test. Although antigenic cross-reactivity exists between M protein type 5 and type 6 group A streptococci, this phenomenon is unlikely to have accounted for the preferential occurrence of type 5 antibodies in rheumatic fever sera. The enzyme-linked immunosorbent assay and opsonic antibody results suggest that M5 is an important rheumatogenic type in Chile.",
author = "Bisno, {A. L.} and X. Berrios and F. Quesney and Monroe, {D. M.} and James Dale and Beachey, {E. H.}",
year = "1982",
language = "English (US)",
volume = "38",
pages = "573--579",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever

AU - Bisno, A. L.

AU - Berrios, X.

AU - Quesney, F.

AU - Monroe, D. M.

AU - Dale, James

AU - Beachey, E. H.

PY - 1982

Y1 - 1982

N2 - Group A streptococci of M protein type 5 have been epidemiologically related to acute rheumatic fever in a number of reported outbreaks. Preliminary bacteriological evidence suggests that M5 may be an important 'rheumatogenic' type in Santiago, Chile. To assess further the relationship of this streptococcal serotype to rheumatic fever in Chile, sera of 34 patients with rheumatic fever and a equal number of age-, sex-, and race-matched controls were assayed for antibodies to types 5, 6, and 24 in an enzyme-linked immunosorbent assay with purified pepsin extracts of the respective M proteins as solid-phase antigens. Sera of 11 rheumatic fever patients (32%) were positive (titer > 1:800) for type 5 antibodies, but only 1 (3%) of the matched controls was positive (P < 0.01). Neither the patients nor the controls had antibodies to type 24. Although 38% of the patient sera contained antibodies to type 6, 29% of the control sera also had such antibodies (P > 0.20). The enzyme-linked immunosorbent assay served as an accurate predictor of which sera contained type 5 opsonic antibodies as measured by the opsonophagocytic test. Although antigenic cross-reactivity exists between M protein type 5 and type 6 group A streptococci, this phenomenon is unlikely to have accounted for the preferential occurrence of type 5 antibodies in rheumatic fever sera. The enzyme-linked immunosorbent assay and opsonic antibody results suggest that M5 is an important rheumatogenic type in Chile.

AB - Group A streptococci of M protein type 5 have been epidemiologically related to acute rheumatic fever in a number of reported outbreaks. Preliminary bacteriological evidence suggests that M5 may be an important 'rheumatogenic' type in Santiago, Chile. To assess further the relationship of this streptococcal serotype to rheumatic fever in Chile, sera of 34 patients with rheumatic fever and a equal number of age-, sex-, and race-matched controls were assayed for antibodies to types 5, 6, and 24 in an enzyme-linked immunosorbent assay with purified pepsin extracts of the respective M proteins as solid-phase antigens. Sera of 11 rheumatic fever patients (32%) were positive (titer > 1:800) for type 5 antibodies, but only 1 (3%) of the matched controls was positive (P < 0.01). Neither the patients nor the controls had antibodies to type 24. Although 38% of the patient sera contained antibodies to type 6, 29% of the control sera also had such antibodies (P > 0.20). The enzyme-linked immunosorbent assay served as an accurate predictor of which sera contained type 5 opsonic antibodies as measured by the opsonophagocytic test. Although antigenic cross-reactivity exists between M protein type 5 and type 6 group A streptococci, this phenomenon is unlikely to have accounted for the preferential occurrence of type 5 antibodies in rheumatic fever sera. The enzyme-linked immunosorbent assay and opsonic antibody results suggest that M5 is an important rheumatogenic type in Chile.

UR - http://www.scopus.com/inward/record.url?scp=0019906431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019906431&partnerID=8YFLogxK

M3 - Article

C2 - 6754620

AN - SCOPUS:0019906431

VL - 38

SP - 573

EP - 579

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 2

ER -